ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682825; 2) Community: the network communities that were significantly associated with the response to NSC 682825; 3) Molecule: the relationships between components within communities and NSC 682825; 4) MDR: the compounds that were significantly associated with the NSC 682825.

NSC Compound Enrichment Correlation
NSC 710336 Null 0.0105972823829603 0.64369075
NSC 711733 Null 0.0105972823829603 0.45787707
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 0.0105972823829603 0.53316374
NSC 718730 Null 0.0105972823829603 0.56623857
NSC 724855 N,N,N,N-Tetraethyl-thieno[3,4-f][1,2,3,4,5]pentathiepine-6 ,8-diamine 0.0105972823829603 0.51563273
NSC 732841 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3-trifluoromethylbenzene 0.0105972823829603 0.45575676
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.0105972823829603 0.45696409
NSC 749296 2-methoxy-5H-pyrido[3,2:4,5]pyrrolo[3,2-c]cinnoline 0.0105972823829603 0.54820933
NSC 758662 Lovastatin [USAN] 0.0105972823829603 -0.046184301
NSC 760979 Null 0.0105972823829603 0.12395065
Total:161  Current:67    [First] [Prev] [Next] [Last]